Tag: Trevo
FDA expands treatment window for use of clot retrieval devices in...
The US Food and Drug Administration has cleared the use of the Trevo clot retrieval device to treat certain stroke patients up to 24...
DEFUSE 3 terminated early with high likelihood of benefit in the...
Following an interim analysis of data from the first 182 patients enrolled in DEFUSE 3, the trial has been terminated and is no longer...
“It’s About Time…!”
In this supplement:
Clinical excellence: Use of real-world data to advance stroke care
DAWN Trial results demonstrate a 73% reduction in disability in stroke...
Physiological time is brain
The DAWN trial results, presented at the European Stroke Organisation Conference (ESOC) by Tudor Jovin and Raul Nogueira, dramatically change the landscape for treatment...
DAWN of a new era: Time to save brain may be...
The much-anticipated results from the DAWN trial were finally revealed at the European Stroke Organisation Conference (ESOC; 16–18 May, Prague, Czech Republic) strongly indicating...
Enrolment stopped early in DAWN trial
An early end to patient enrolment in the DAWN trial has been activated following a pre-planned interim analysis of the data from the first...
US FDA broadens treatment indication for Stryker’s Trevo device
The US Food and Drug Administration (FDA) has allowed marketing of two Trevo (Stryker Neurovascular) clot retrieval devices as an initial therapy for ischaemic...
Thousandth patient enrolled in Stryker’s Trevo Retriever Registry
Data from the first 500 patients enrolled in the Trevo Registry were presented at the European Stroke Organisation Conference (ESOC; 10-12 May, Barcelona, Spain)...
“Push & Fluff” deployment proves better for radiopaque retriever
While the traditional unsheathing technique for the deployment of stent retrievers has proved successful in clinical use, in their experience, Raul Gomes Nogueira (Emory...
Study suggests feasibility of Baby Trevo for treatment of distal cerebrovascular...
Diogo Haussen and colleagues (Emory University School of Medicine, Atlanta, USA) report that their initial data suggest that treatment of distal cerebrovascular occlusions with...
Foreign body retrieval could be new indication for Trevo ProVue in...
A case report has described the novel use of a stent for the removal of a foreign body from the cerebrovascular system.
Stryker launches Trevo XP ProVue retrieval system
Stryker has launched the Trevo XP ProVue retrieval system, a second generation fully visible stent retriever to treat acute ischaemic stroke.
